First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection.
Am J Transplant
; 22(12): 3143-3145, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-1978412
ABSTRACT
Post-coronavirus disease 2019 (COVID-19) cholangiopathy (PCC) is a new entity observed in patients recovering from severe COVID-19 pneumonia. Most patients recover with cholestasis improving over a period of time. In some patients, cholestasis is severe and persists or progresses to liver failure necessitating liver transplant. We present a previously healthy 50-year-old man who developed PCC with peak total bilirubin of 42.4 mg/dl and did not improve with medical management. He underwent living donor auxiliary right lobe liver transplantation. He recovered well after transplant and remains asymptomatic at 6 months follow-up with good graft function and recovering function in native liver remnant.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cholestasis
/
Liver Transplantation
/
COVID-19
Type of study:
Case report
/
Cohort study
/
Prognostic study
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Am J Transplant
Journal subject:
Transplantation
Year:
2022
Document Type:
Article
Affiliation country:
Ajt.17165
Similar
MEDLINE
...
LILACS
LIS